Sunday 18 October 2026
Export IVF’s income statement to Excel — free account
INVO Fertility, Inc
IVF Healthcare Medical Devices
INVO Fertility, Inc’s revenue for fiscal 2025 (year ended December 2025) was $6.8 million, up 4.74% from fiscal 2024. In the quarter to June 2026, revenue grew 16.7%, EPS grew 100.1%, free cash flow grew 35.1% and total debt fell 50.7%, each against the same quarter a year earlier. Revenue growth for three consecutive years.
0.56
0.03
−5.08%
Follow IVF
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
3 | 4 | 4 | 4 |
| 518.04% | 387.43% | 213.69% | (203.65%) | ||
| (154.55%) | (75.81%) | (47.04%) | (38.79%) | ||
ROIC |
(73.85%) | (76.78%) | (44.23%) | (27.92%) | |
Return on Tangible Assets |
359.68% | 349.81% | 9,024.49% | 807.96% | |
Average Days of Receivables |
14.41 | 11.59 | 12.56 | 12.49 | |
Free Cash Flow per Share |
(90.11) | (60.32) | (3.29) | (2.29) | |
Free Cash Flow |
(7.77) | (7.06) | (5.39) | (4.82) | |
Capital Expenditures |
(0.11) | (0.04) | — | (0.05) | |
| Other line items | |||||
Cash ROIC |
(106.32%) | (70.25%) | (26.16%) | (23.23%) | |
Accounts Receivable Turnover |
26.14 | 41.41 | 34.21 | 30.12 | |
Accounts Payable Turnover |
1.67 | 1.68 | 1.41 | 2.55 | |
Inventory Turnover |
19.50 | 19.38 | 20.65 | 21.01 | |
Average Days of Payables |
206.65 | 172.15 | 133.67 | 119.88 | |
Days of Inventory on Hand |
16.58 | 19.07 | 18.00 | 18.82 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.03 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
120.13% | 112.42% | 115.11% | 106.54% | |
Share Based Compensation of Revenue |
17.08% | 18.86% | 18.23% | 9.52% | |
Interest Coverage |
(7.05) | (5.56) | (6.50) | (6.51) | |
Operating CF/Net income |
0.28 | 0.28 | 0.41 | 0.54 | |
Depreciation/Fixed assets |
2.45 | 4.82 | 3.54 | 1.67 | |
Capex/Depreciation |
(0.11) | (0.02) | 0.00 | (0.03) | |
Revenue per Share |
80.56 | 58.47 | 4.41 | 3.58 | |
Operating CF per Share |
(88.83) | (59.95) | (3.29) | (2.26) | |
Capex per Share |
(1.28) | (0.37) | 0.00 | (0.02) | |
Capex to Sales |
0.02 | 0.01 | 0.00 | 0.01 |
Columns are period end dates